BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30347501)

  • 1. Ubiquitin-independent, Proteasome-mediated targeted degradation of KRAS in pancreatic adenocarcinoma cells using an engineered ornithine decarboxylase/antizyme system.
    Ma Y; Xu J; Huang P; Bai X; Gao H
    IUBMB Life; 2019 Jan; 71(1):57-65. PubMed ID: 30347501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted degradation of KRAS by an engineered ubiquitin ligase suppresses pancreatic cancer cell growth in vitro and in vivo.
    Ma Y; Gu Y; Zhang Q; Han Y; Yu S; Lu Z; Chen J
    Mol Cancer Ther; 2013 Mar; 12(3):286-94. PubMed ID: 23288781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of ornithine decarboxylase by the 26S proteasome.
    Murakami Y; Matsufuji S; Hayashi S; Tanahashi N; Tanaka K
    Biochem Biophys Res Commun; 2000 Jan; 267(1):1-6. PubMed ID: 10623564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of antizyme inhibitor, an ornithine decarboxylase homologous protein, is ubiquitin-dependent and is inhibited by antizyme.
    Bercovich Z; Kahana C
    J Biol Chem; 2004 Dec; 279(52):54097-102. PubMed ID: 15491992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method for targeting protein destruction by using a ubiquitin-independent, proteasome-mediated degradation pathway.
    Matsuzawa S; Cuddy M; Fukushima T; Reed JC
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):14982-7. PubMed ID: 16219697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of antizyme-mediated regulation of polyamine homeostasis.
    Wu HY; Chen SF; Hsieh JY; Chou F; Wang YH; Lin WT; Lee PY; Yu YJ; Lin LY; Lin TS; Lin CL; Liu GY; Tzeng SR; Hung HC; Chan NL
    Proc Natl Acad Sci U S A; 2015 Sep; 112(36):11229-34. PubMed ID: 26305948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of ornithine decarboxylase by the mammalian and yeast 26S proteasome complexes requires all the components of the protease.
    Elias S; Bercovich B; Kahana C; Coffino P; Fischer M; Hilt W; Wolf DH; Ciechanover A
    Eur J Biochem; 1995 Apr; 229(1):276-83. PubMed ID: 7744041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifaceted interactions and regulation between antizyme and its interacting proteins cyclin D1, ornithine decarboxylase and antizyme inhibitor.
    Liu YC; Lee CY; Lin CL; Chen HY; Liu GY; Hung HC
    Oncotarget; 2015 Sep; 6(27):23917-29. PubMed ID: 26172301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of protein degradation: an odyssey with ODC.
    Kahana C; Asher G; Shaul Y
    Cell Cycle; 2005 Nov; 4(11):1461-4. PubMed ID: 16205122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ornithine decarboxylase-antizyme is rapidly degraded through a mechanism that requires functional ubiquitin-dependent proteolytic activity.
    Gandre S; Bercovich Z; Kahana C
    Eur J Biochem; 2002 Feb; 269(4):1316-22. PubMed ID: 11856366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degrons of yeast and mammalian ornithine decarboxylase enzymes make potent combination for regulated targeted protein degradation.
    Joshi RG; Ratna Prabha C
    Appl Microbiol Biotechnol; 2017 Apr; 101(7):2905-2917. PubMed ID: 28013404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of polyamine homeostasis through an antizyme citrullination pathway.
    Yang YF; Lee CY; Hsieh JY; Liu YL; Lin CL; Liu GY; Hung HC
    J Cell Physiol; 2021 Aug; 236(8):5646-5663. PubMed ID: 33432662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP-Dependent inactivation and sequestration of ornithine decarboxylase by the 26S proteasome are prerequisites for degradation.
    Murakami Y; Matsufuji S; Hayashi SI; Tanahashi N; Tanaka K
    Mol Cell Biol; 1999 Oct; 19(10):7216-27. PubMed ID: 10490656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear translocation of antizyme and expression of ornithine decarboxylase and antizyme are developmentally regulated.
    Gritli-Linde A; Nilsson J; Bohlooly-Y M; Heby O; Linde A
    Dev Dyn; 2001 Mar; 220(3):259-75. PubMed ID: 11241834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eflornithine (DFMO) prevents progression of pancreatic cancer by modulating ornithine decarboxylase signaling.
    Mohammed A; Janakiram NB; Madka V; Ritchie RL; Brewer M; Biddick L; Patlolla JM; Sadeghi M; Lightfoot S; Steele VE; Rao CV
    Cancer Prev Res (Phila); 2014 Dec; 7(12):1198-209. PubMed ID: 25248858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the proteasome and antizyme in ornithine decarboxylase degradation by a reticulocyte lysate.
    Murakami Y; Matsufuji S; Tanaka K; Ichihara A; Hayashi S
    Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):305-8. PubMed ID: 8216232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yeast antizyme mediates degradation of yeast ornithine decarboxylase by yeast but not by mammalian proteasome: new insights on yeast antizyme.
    Porat Z; Landau G; Bercovich Z; Krutauz D; Glickman M; Kahana C
    J Biol Chem; 2008 Feb; 283(8):4528-34. PubMed ID: 18089576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination.
    Murakami Y; Matsufuji S; Kameji T; Hayashi S; Igarashi K; Tamura T; Tanaka K; Ichihara A
    Nature; 1992 Dec; 360(6404):597-9. PubMed ID: 1334232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1.
    Asher G; Bercovich Z; Tsvetkov P; Shaul Y; Kahana C
    Mol Cell; 2005 Mar; 17(5):645-55. PubMed ID: 15749015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unified pathway for the degradation of ornithine decarboxylase in reticulocyte lysate requires interaction with the polyamine-induced protein, ornithine decarboxylase antizyme.
    Mamroud-Kidron E; Omer-Itsicovich M; Bercovich Z; Tobias KE; Rom E; Kahana C
    Eur J Biochem; 1994 Dec; 226(2):547-54. PubMed ID: 8001569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.